[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Drugs Market Research Reports & Industry Analysis

The drugs industry is an enormous multibillion businesses encompassing an immense number of companies involved in the design, production and marketing of drugs worldwide. According to the type of drugs the market can be dived into the following segments: diabetes, antifungal, antidepressant, antithrombotic, hepatitis drugs, analgesics and a far more.

Currently, the drugs market is undergoing a recovery phase in the wake of the recent decline provoked by the economic slump. The market growth is spurred by increasing demand for drugs across the globe, rising incidence of chronic as well as infectious diseases, population ageing, product innovations and constant technological advancements. North America and Europe are the most prominent regional markets. Bristol-Myers Squibb, Pharmacia, GlaxoSmithKline, Merck & Co, Novartis, Eli Lilly, Pfizer, Johnson & Johnson, Allergan, Schering-Plough, Bayer and Abbott Labs are amid global drugs arena giants.

A huge collection of the research reports covering the drugs market at different geographies can be found under this MarketPublishers’ catalogue. The researches provide comprehensive assessment of the market, characterize major market trends and disclose essential market indicators. The reports describe the competitive scenario and indicate top market players. In addition, future prospects for the drugs market are thoroughly studied in the research reports.

Publications found: 8,499
Sort by:

Secondary Hyperparathyroidism (Hormonal Disorders) - Drugs in Development, 2021

US$ 2,000.00

Secondary Hyperparathyroidism (Hormonal Disorders) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Secondary Hyperparathyroidis...

March 2021 63 pages

Sedation (Central Nervous System) - Drugs in Development, 2021

US$ 2,000.00

Sedation (Central Nervous System) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Sedation - Drugs in Development, 2021, provid...

March 2021 64 pages

Serine Protein Kinase ATM (Ataxia Telangiectasia Mutated or ATM or EC 2.7.11.1) - Drugs in Development, 2021

US$ 3,500.00

Serine Protein Kinase ATM (Ataxia Telangiectasia Mutated or ATM or EC 2.7.11.1) - Drugs in Development, 2021 SUMMARY Serine Protein Kinase ATM (Ataxia Telangiectasia Mutated or ATM or EC 2.7.11.1) pip...

March 2021 35 pages

Serine/Threonine Protein Kinase Pim 1 (Oncogene PIM1 or PIM1 or EC 2.7.11.1) - Drugs in Development, 2021

US$ 3,500.00

Serine/Threonine Protein Kinase Pim 1 (Oncogene PIM1 or PIM1 or EC 2.7.11.1) - Drugs in Development, 2021 SUMMARY Serine/Threonine Protein Kinase Pim 1 (Oncogene PIM1 or PIM1 or EC 2.7.11.1) - Proto-o...

March 2021 56 pages

Serine/Threonine Protein Kinase Pim 2 (Pim 2h or Proto Oncogene Pim 2 or PIM2 or EC 2.7.11.1) - Drugs in Development, 2021

US$ 3,500.00

Serine/Threonine Protein Kinase Pim 2 (Pim 2h or Proto Oncogene Pim 2 or PIM2 or EC 2.7.11.1) - Drugs in Development, 2021 SUMMARY According to the recently published report 'SerineThreonine Protein K...

March 2021 46 pages

Serine/Threonine Protein Kinase Pim 3 (Pim 3 Oncogene or PIM3 or EC 2.7.11.1) - Drugs in Development, 2021

US$ 3,500.00

Serine/Threonine Protein Kinase Pim 3 (Pim 3 Oncogene or PIM3 or EC 2.7.11.1) - Drugs in Development, 2021 SUMMARY Serine/Threonine Protein Kinase Pim 3 (Pim 3 Oncogene or PIM3 or EC 2.7.11.1) pipelin...

March 2021 46 pages

Smallpox (Infectious Disease) - Drugs in Development, 2021

US$ 2,000.00

Smallpox (Infectious Disease) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Smallpox - Drugs in Development, 2021, provides a...

March 2021 88 pages

Streptococcus pyogenes Infections (Infectious Disease) - Drugs in Development, 2021

US$ 2,000.00

Streptococcus pyogenes Infections (Infectious Disease) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Streptococcus pyogenes I...

March 2021 34 pages

Systemic Sclerosis (Scleroderma) (Immunology) - Drugs in Development, 2021

US$ 2,500.00

Systemic Sclerosis (Scleroderma) (Immunology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Systemic Sclerosis - Drugs in Dev...

March 2021 489 pages

TGF Beta Receptor Type 2 (Transforming Growth Factor Beta Receptor Type II or TGFBR2 or EC 2.7.11.30) - Drugs in Development, 2021

US$ 3,500.00

TGF Beta Receptor Type 2 (Transforming Growth Factor Beta Receptor Type II or TGFBR2 or EC 2.7.11.30) - Drugs in Development, 2021 SUMMARY According to the recently published report 'TGF Beta Receptor...

March 2021 36 pages

Thromboembolism (Cardiovascular) - Drugs in Development, 2021

US$ 2,000.00

Thromboembolism (Cardiovascular) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Thromboembolism - Drugs in Development, 2021,...

March 2021 165 pages

Toll Like Receptor 3 (CD283 or TLR3) - Drugs in Development, 2021

US$ 3,500.00

Toll Like Receptor 3 (CD283 or TLR3) - Drugs in Development, 2021 SUMMARY Toll Like Receptor 3 (CD283 or TLR3) pipeline Target constitutes close to 12 molecules. Out of which approximately 10 molecule...

March 2021 91 pages

Toll Like Receptor 8 (CD288 or TLR8) - Drugs in Development, 2021

US$ 3,500.00

Toll Like Receptor 8 (CD288 or TLR8) - Drugs in Development, 2021 SUMMARY Toll Like Receptor 8 (CD288 or TLR8) - Toll-like receptor 8 is a protein encoded by the TLR8 gene. It control host immune resp...

March 2021 111 pages

Tourette Syndrome (Central Nervous System) - Drugs in Development, 2021

US$ 2,000.00

Tourette Syndrome (Central Nervous System) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Tourette Syndrome - Drugs in Develop...

March 2021 74 pages

Transforming Growth Factor Beta 1 (TGFB1) - Drugs in Development, 2021

US$ 3,500.00

Transforming Growth Factor Beta 1 (TGFB1) - Drugs in Development, 2021 SUMMARY Transforming Growth Factor Beta 1 (TGFB1) - Transforming growth factor beta 1 (TGF-?1) is a polypeptide member of the tra...

March 2021 116 pages

Traumatic Brain Injury (Central Nervous System) - Drugs in Development, 2021

US$ 2,500.00

Traumatic Brain Injury (Central Nervous System) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Traumatic Brain Injury - Drugs...

March 2021 514 pages

Typhoid Fever (Infectious Disease) - Drugs in Development, 2021

US$ 2,000.00

Typhoid Fever (Infectious Disease) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Typhoid Fever - Drugs in Development, 2021,...

March 2021 57 pages

Tyrosine Protein Kinase JAK1 (Janus Kinase 1 or JAK1 or EC 2.7.10.2) - Drugs in Development, 2021

US$ 3,500.00

Tyrosine Protein Kinase JAK1 (Janus Kinase 1 or JAK1 or EC 2.7.10.2) - Drugs in Development, 2021 SUMMARY According to the recently published report 'Tyrosine Protein Kinase JAK1 - Drugs in Developmen...

March 2021 305 pages

Tyrosine Protein Kinase JAK2 (Janus Kinase 2 or JAK2 or EC 2.7.10.2) - Drugs in Development, 2021

US$ 3,500.00

Tyrosine Protein Kinase JAK2 (Janus Kinase 2 or JAK2 or EC 2.7.10.2) - Drugs in Development, 2021 SUMMARY Tyrosine Protein Kinase JAK2 (Janus Kinase 2 or JAK2 or EC 2.7.10.2) pipeline Target constitut...

March 2021 213 pages

Tyrosine Protein Kinase JAK3 (Janus Kinase 3 or Leukocyte Janus Kinase or JAK3 or EC 2.7.10.2) - Drugs in Development, 2021

US$ 3,500.00

Tyrosine Protein Kinase JAK3 (Janus Kinase 3 or Leukocyte Janus Kinase or JAK3 or EC 2.7.10.2) - Drugs in Development, 2021 SUMMARY Tyrosine Protein Kinase JAK3 (Janus Kinase 3 or Leukocyte Janus Kina...

March 2021 147 pages

Tyrosine Protein Kinase SYK (Spleen Tyrosine Kinase or p72 Syk or SYK or EC 2.7.10.2) - Drugs in Development, 2021

US$ 3,500.00

Tyrosine Protein Kinase SYK (Spleen Tyrosine Kinase or p72 Syk or SYK or EC 2.7.10.2) - Drugs in Development, 2021 SUMMARY According to the recently published report 'Tyrosine Protein Kinase SYK - Dru...

March 2021 135 pages

Urinary Incontinence (Genitourinary Disorders) - Drugs in Development, 2021

US$ 2,000.00

Urinary Incontinence (Genitourinary Disorders) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Urinary Incontinence - Drugs in...

March 2021 72 pages

Uterine Leiomyoma (Uterine Fibroids) (Non Malignant Disorders) - Drugs in Development, 2021

US$ 2,000.00

Uterine Leiomyoma (Uterine Fibroids) (Non Malignant Disorders) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Uterine Leiomyom...

March 2021 127 pages

Venous Leg Ulcers (Crural ulcer) (Dermatology) - Drugs in Development, 2021

US$ 2,000.00

Venous Leg Ulcers (Crural ulcer) (Dermatology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Venous Leg Ulcers - Drugs in Dev...

March 2021 79 pages

Ventilator Associated Pneumonia (VAP) (Infectious Disease) - Drugs in Development, 2021

US$ 2,000.00

Ventilator Associated Pneumonia (VAP) (Infectious Disease) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Ventilator Associate...

March 2021 203 pages

Warts (Infectious Disease) - Drugs in Development, 2021

US$ 2,000.00

Warts (Infectious Disease) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Warts - Drugs in Development, 2021, provides an over...

March 2021 117 pages

Drug Discovery Technologies

US$ 2,750.00

... among others. Key players in the drug discovery market include Thermo Fisher Scientific, Agilent Technologies Inc., Shimadzu Corp., Bruker Corp., ... 23 additional tables. An overview of the global markets for drug discovery technologies. Analyses of global market trends with data from 2015, 2016, and 2017, ...

March 2021 193 pages

Immunotherapy Drugs: Global Markets

US$ 2,750.00

Report : The global immunotherapy market can be segmented into the following types: checkpoint inhibitors, monoclonal antibodies, interferons and interleukins. This report does not include other immun...

March 2021 143 pages

Omega-3 Polyunsaturated Fatty Acids (PUFAs) – A Global Market Overview

US$ 4,500.00

... ) ingredients market analyzed in this study include EPA and DHA omega-3s from marine oils such as fish oils, krill oils and ... nutrition, pharmaceuticals and clinical nutrition. Worldwide, consumption of Omega-3 polyunsaturated fatty acids (PUFAs), estimated at 123.8 thousand metric tons worth US$2.3 billion in ...

March 2021 372 pages

The US Drug Eluting Sinus Stent (DESS) Market: Size, Trends & Forecasts (2021-2025 Edition)

US$ 850.00

of the Report The report titled “The US Drug Eluting Sinus Stent (DESS) Market: Size, Trends & Forecasts (2021-2025 Edition)”, provides an in depth analysis of the US drug eluting sinus stent (DESS)...

March 2021 71 pages

Global Psychedelic Drugs Market: Size & Forecast with Impact Analysis of COVID-19 (2021-2025)

US$ 850.00

of the Report The report titled “Global Psychedelic Drugs Market: Size & Forecast with Impact Analysis of COVID-19 (2021-2025)”, provides an in depth analysis of the global psychedelic drugs market b...

March 2021 77 pages

United States Generic Drugs Market By Segment (Generic, Branded), Therapeutic Application, Company Analysis & Forecast

US$ 2,290.00

Generics are an off-patented drug that is pharmaceutical equivalents to branded medicines in term of administrative dosage, quality, effect, intended use and side effects. In the United States, generi...

March 2021 110 pages

Global RET Inhibitors Drug Market Opportunity & Clinical Trials Insight 2026

US$ 2,400.00

Please note: extra shipping charges are applied when purchasing Hard Copy License depending on the location. 'Global RET Inhibitors Drug Market Opportunity & Clinical Trials Insight 2026' Report Hig...

March 2021 150 pages

Drug Of Abuse Testing Services Market Size, Share & Trends Analysis Report By Drug Type (Cannabis/Marijuana, Opioids, Cocaine, Alcohol, LSD, Amphetamine & Methamphetamine), By Region, And Segment Forecasts, 2021 - 2028

US$ 5,950.00

The global drug of abuse testing services market is expected to reach USD 2.9 billion by 2025, according to a new report by ... . Further Key Findings From the Report Suggest: The global drug of abuse testing services market size was estimated at USD 1,465.4 million in 2016 and ...

February 2021 125 pages

Drug Discovery Informatics Market Size, Share & Trends Analysis Report By Mode (In-house, Outsourced), By Workflow (Discovery, Development), By Services (Sequence Analysis Platforms, Docking), And Segment Forecasts, 2021 - 2028

US$ 5,950.00

... drug discovery informatics market size is expected to reach USD 2.07 billion by 2025, according to a new report by Grand View Research, Inc., progressing at a CAGR of 12.6% during the forecast period. Drug ...

February 2021 150 pages

Anticoagulant Reversal Drugs Market Size, Share & Trends Analysis Report By Product Type (Prothrombin Complex Concentrates, Phytonadione, Andexanet Alfa, Idarucizumab, Protamine), By Distribution Channel, And Segment Forecasts, 2020 - 2027

US$ 5,950.00

This report can be delivered to the clients within 72 Business Hours Anticoagulant Reversal Drugs Market Growth & Trends The global anticoagulant reversal drugs market size is expected to reach USD...

February 2021 110 pages

Allergy Drugs Market Research Report by Type (Drug Allergy, Food Allergy, and Inhaled Allergy), by Treatment (Anti-allergy Drugs and Immunotherapy), by Distribution Channels - Global Forecast to 2025 - Cumulative Impact of COVID-19

US$ 3,949.00

Market Statistics: The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchang...

February 2021 183 pages

Antibiotics Market Research Report by Drug Class (Aminoglycosides, Carbapenem, Cephalosporin, Fluoroquinolone, and Macrolides), by Action Mechanism (Cell Wall Synthesis Inhibitors, DNA Synthesis Inhibitors, Mycolic Acid Inhibitors, Protein Synthesis Inhibitors, and RNA Synthesis Inhibitors) - Global Forecast to 2025 - Cumulative Impact of COVID-19

US$ 3,949.00

Market Statistics: The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchang...

February 2021 193 pages

Antidiabetic Drug Market Research Report by Type (Alpha-glucosidase Inhibitors, Biguanides, DPP-IV (Dipeptidyl Peptidase) Inhibitors, GLP-1 (Glucagon-like Peptide) Agonists, and Insulin), by Disease (Diabetes Mellitus Type 1 and Diabetes Mellitus Type 2), by Patient - Global Forecast to 2025 - Cumulative Impact of COVID-19

US$ 3,949.00

Market Statistics: The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchang...

February 2021 194 pages

IV and Oral Iron Drugs Market - Global Outlook and Forecast 2021-2026

US$ 3,750.00

... IV and oral iron drugs market by ROA can be segmented ino oral iron drugs and intravenous (IV) iron drugs. The oral iron drugs segment captured more than half of the market in 2018. Oral iron drugs are ...

February 2021 342 pages

Analgesics Market Research Report by Type (Non-opioids and Opioids), by Route of Administration (Intravenous, Oral, Rectal, Topical, and Transdermal) - Global Forecast to 2025 - Cumulative Impact of COVID-19

US$ 3,949.00

Market Statistics: The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchang...

February 2021 184 pages

Hormonal Contraceptives Market Research Report by Hormone Type (Androgens, Antiandrogens, Estrogens, Gonadotropins, and Progestogens), by Method Type (Combined Oral Contraceptives, Implanted Contraceptives, Injected Contraceptives, Intrauterine, and Oral Contraceptives), by End-user - Global Forecast to 2025 - Cumulative Impact of COVID-19

US$ 3,949.00

Market Statistics: The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchang...

February 2021 198 pages

US General Anesthesia Drugs Market by Route of Administration (Intravenous and Inhalational), End User (Hospitals, Ambulatory Surgery Centers) - Forecast to 2025

US$ 4,950.00

... on the following pointers: Market Penetration: Comprehensive information on product portfolios of the top players in the U.S. general anesthesia drugs market. The report analyzes the U.S. general anesthesia drugs market by molecule and mode of administration. Competitive Assessment: In-depth assessment of the market strategies, geographic and ...

February 2021 117 pages

Antibiotics Market Size, Share & Trends Analysis Report By Drug Class (Cephalosporin, Penicillin, Fluoroquinolone, Macrolide, Carbapenem, Aminoglycoside, Sulfonamide, 7-ACA), By Action Mechanism, And Segment Forecasts, 2021 - 2028

US$ 5,950.00

The global antibiotics market size is expected to reach USD 62.06 billion by 2025 expanding at a CAGR of 4.0%, according to a new ... . Government reforms specific to antibiotics, such as the Generating Antibiotics Incentives Now (GAIN) Act in U.S., are projected to help boost the market growth over the ...

February 2021 120 pages

Chemotherapy Induced Nausea and Vomiting - Pipeline Insight, 2021

US$ 1,500.00

... chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Chemotherapy Induced Nausea and Vomiting The report also ...

February 2021 80 pages

Gallbladder cancer - Pipeline Insight, 2021

US$ 1,500.00

... clients within 48 Hours 'Gallbladder Cancer - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Gallbladder Cancer development. The report provides ...

February 2021 60 pages

Yellow Fever- Pipeline Insight, 2021

US$ 1,500.00

... clients within 48 Hours 'Yellow Fever - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Yellow Fever development. The report provides ...

February 2021 60 pages

Chronic inflammatory demyelinating polyneuropathy (CIDP) - Pipeline Insight, 2021

US$ 1,500.00

... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) The report also ...

February 2021 60 pages

End-Stage Renal Disease - Pipeline Insight, 2021

US$ 1,500.00

... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for End-Stage Kidney Disease The report also covers ...

February 2021 60 pages

Filters

Search

Publishers

1
2
1
95
4
1
27
16
4
14
1
3
174
29
9
2,264
5
4
22
51
6
142
16
1
17
1
15
23
651
79
1
373
16
586
4
1
1
2
16
1,197
6
166
4
84
31
2
36
3
5
4
118
187
13
16
4
2
7
15
110
2
10
50
16
26
4
2
17
4
2
1
11
32
8
15
4
24
118
49
2
1
19
4
7
3
324
11
1
1
23
31
4
11
3
1
499
24
2
5
29
44
294
17
17
13
5
18
2

Regions

614
11
4
9
6
12
6
273
158
54
47
41
41
39
37
17
16
16
16
15
14
14
14
14
14
13
13
13
13
13
13
13
13
13
12
12
11
11
11
10
10
10
10
10
10
9
9
9
9
9
9
9
9
8
7
7
6
6
6
5
4
4
4
3
192
10
5
4
4
4
4
4
3
3
3
3
3
3
1
1
7
6
3
8
2
1
2
183
1
5
3
11
11
7
5
16
9
6
16
14
4
150
248
5,652
11

Price

Date

Pages

Offers

13
7
9
1
498